Assignee
UCB PHARMA GMBH
DE·31 granted patents·16 pending applications·143 citations·filing 2002–2023
Top patents by PatentIndex Score
47 records- 0190US8008351B2Methods for prophylaxis or treatment of conditions associated with cortical spreading depressionUCB PHARMA GMBH·Filed 2005·Granted Aug 30, 2011·10 cites·29 claims
- 0289US7718161B2Method for treating a motoneuron disorderUCB PHARMA GMBH·Filed 2008·Granted May 18, 2010·15 cites·11 claims
- 0388US9446011B2Anticonvulsant combination therapyUCB PHARMA GMBH·Filed 2015·Granted Sep 20, 2016·7 cites·17 claims
- 0488US8053476B2Method for treating peripheral neuropathic painUCB PHARMA GMBH·Filed 2006·Granted Nov 8, 2011·11 cites·17 claims
- 0586US9095557B2Anticonvulsant combination therapyUCB PHARMA GMBH·Filed 2013·Granted Aug 4, 2015·8 cites·22 claims
- 0686US7807715B2Pharmaceutical compositions comprising fesoterodineUCB PHARMA GMBH·Filed 2007·Granted Oct 5, 2010·5 cites·9 claims
- 0785US7884134B2Synthesis scheme for lacosamideUCB PHARMA GMBH·Filed 2005·Granted Feb 8, 2011·18 cites·20 claims
- 0885US7820857B2Method for treating pain in trigeminal neuralgiaUCB PHARMA GMBH·Filed 2005·Granted Oct 26, 2010·13 cites·20 claims
- 0984US7872041B2Use of rotigotine for treating and preventing Parkinson's plus syndromeUCB PHARMA GMBH·Filed 2005·Granted Jan 18, 2011·10 cites·31 claims
- 1083US7982058B2Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereofUCB PHARMA GMBH·Filed 2007·Granted Jul 19, 2011·4 cites·9 claims
- 1180US7985772B2Derivatives of 3,3-diphenylpropylaminesUCB PHARMA GMBH·Filed 2010·Granted Jul 26, 2011·3 cites·8 claims
- 1280US7794987B2Method for treating central neuropathic painUCB PHARMA GMBH·Filed 2004·Granted Sep 14, 2010·14 cites·32 claims
- 1379US7875652B2Method and composition for treating pain or tinnitus aureumUCB PHARMA GMBH·Filed 2002·Granted Jan 25, 2011·11 cites·10 claims
- 1479US7855230B2Derivatives of 3,3-diphenylpropylaminesUCB PHARMA GMBH·Filed 2008·Granted Dec 21, 2010·2 cites·5 claims
- 1578US10350174B2Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotineUCB PHARMA GMBH·Filed 2018·Granted Jul 16, 2019·1 cites·16 claims
- 1677US9034914B2Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresisUCB PHARMA GMBH·Filed 2014·Granted May 19, 2015·2 cites·12 claims
- 1774US8044061B28-alkynylxanthines and derivativesUCB PHARMA GMBH·Filed 2007·Granted Oct 25, 2011·7 cites·10 claims
- 1873US2023348384A1Aza (Indole)-, Benzothiophene-, And Benzofuran-3-SulfonamidesUCB PHARMA GMBH·Filed 2023·Application pending·0 cites
- 1972US9108900B2Method of treating diseases that respond to therapy by dopamine or dopamine agonistsUCB PHARMA GMBH·Filed 2013·Granted Aug 18, 2015·2 cites·10 claims
- 2069US7989654B2High purity bases of 3,3-diphenylpropylamino monoestersUCB PHARMA GMBH·Filed 2008·Granted Aug 2, 2011·0 cites·16 claims
- 2167US12071404B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2021·Granted Aug 27, 2024·0 cites·58 claims
- 2267US11820746B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2022·Granted Nov 21, 2023·0 cites·34 claims
- 2366US9364541B2Pharmaceutical compositions comprising FesoterodineUCB PHARMA GMBH·Filed 2013·Granted Jun 14, 2016·0 cites·19 claims
- 2465US2014128378A1Methods of treating epileptogenesisUCB PHARMA GMBH·Filed 2014·Application pending·0 cites
- 2564US10130589B2Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotineUCB PHARMA GMBH·Filed 2018·Granted Nov 20, 2018·0 cites·24 claims
- 2662US2019314294A1Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of RotigotineUCB PHARMA GMBH·Filed 2019·Application pending·0 cites
- 2761US9309215B2Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereofUCB PHARMA GMBH·Filed 2014·Granted Apr 12, 2016·0 cites·12 claims
- 2861US7919117B2Transdermal delivery of (R)-3,3-diphenylpropylamin-monoesternUCB PHARMA GMBH·Filed 2009·Granted Apr 5, 2011·0 cites·24 claims
- 2960US2019328680A1Transdermal Therapeutic System with a Low Tendency to Spontaneously CrystallizeUCB PHARMA GMBH·Filed 2019·Application pending·0 cites
- 3057US2014378917A1Transdermal therapeutic system with a low tendency to spontaneously crystallizeUCB PHARMA GMBH·Filed 2012·Application pending·0 cites
- 3156US11345662B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2017·Granted May 31, 2022·0 cites·47 claims
- 3255US2014128377A1Methods of treating refractory repetitive seizuresUCB PHARMA GMBH·Filed 2014·Application pending·0 cites
- 3352US2015104507A1Formulation of lacosamideUCB PHARMA GMBH·Filed 2014·Application pending·0 cites
- 3451US2019054009A1Daily formulation of lacosamideUCB PHARMA GMBH·Filed 2018·Application pending·0 cites
- 3550US9630908B2Process for preparing lacosamideUCB PHARMA GMBH·Filed 2015·Granted Apr 25, 2017·0 cites·6 claims
- 3650US2019008758A1Lacosamide controlled release formulationUCB PHARMA GMBH·Filed 2018·Application pending·0 cites
- 3749US11976056B2Substituted alkoxypyridinyl indolsulfonamidesUCB PHARMA GMBH·Filed 2019·Granted May 7, 2024·0 cites·20 claims
- 3849US2011082211A1Method for treating tinnitus aureumUCB PHARMA GMBH·Filed 2010·Application pending·0 cites
- 3948US2010260716A1Compounds for treating demyelination conditionsUCB PHARMA GMBH·Filed 2008·Application pending·0 cites
- 4045US2017151215A1Use of rotigotine for treating the restless leg syndromeUCB PHARMA GMBH·Filed 2017·Application pending·0 cites
- 4143US2014066515A1Methods for treating channelopathiesUCB PHARMA GMBH·Filed 2013·Application pending·0 cites
- 4242US11939319B2Pyridinyl and pyrazinyl-(asa)indolsulfonamidesUCB PHARMA GMBH·Filed 2019·Granted Mar 26, 2024·0 cites·34 claims
- 4342US7985873B2Synthesis of phenolic esters of hydroxymethyl phenolsUCB PHARMA GMBH·Filed 2007·Granted Jul 26, 2011·0 cites·18 claims
- 4441US12358875B2N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosisUCB PHARMA GMBH·Filed 2020·Granted Jul 15, 2025·0 cites·23 claims
- 4541US2010256179A1Combination therapy for pain in painful diabetic neuropathyUCB PHARMA GMBH·Filed 2010·Application pending·0 cites
- 4641US2017035733A1Pharmaceutical composition comprising lacosamide and levetiracetamUCB PHARMA GMBH·Filed 2014·Application pending·0 cites
- 4737US2011104281A1Method for treating pain using a substituted 2-aminotetralin compoundUCB PHARMA GMBH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UCB PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →